Regencell Bioscience Holdings RGC
NASDAQ RGC
$5.83 -0.99 (-14.52%)
As of: Sep 9, 2026 · 2:28 PM EDT

Regencell Bioscience Holdings (RGC) Shares Issued (2022)

Regencell Bioscience Holdings' (RGC) quarterly Shares Issued came in at $301085.0 in Q2 2022.

Analysis

Regencell Bioscience Holdings (RGC) Shares Issued (2022) Analysis & Trends

Regencell Bioscience Holdings (RGC) has reported Shares Issued for 1 consecutive years, with $301085.0 the latest figure, recorded in Q2 2022.

  • For the quarter ending Q2 2022, Shares Issued changed N/A year-over-year to $301085.0; the trailing twelve-month figure through Jun 2022 stood at $301085.0 (changed N/A YoY), and the FY2022 full-year result was $301085.0, changed N/A from the prior year.
  • Shares Issued was little changed at $301085.0 in Q2 2022 per RGC's latest filing.
  • Across five years, Shares Issued topped out at $301085.0 in Q2 2022 and bottomed at $301085.0 in Q2 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Issued (Qtr)
1 Johnson & Johnson 646.53 Bn 625.77 Bn 17.26 Bn -
2 AbbVie 442.27 Bn 435.70 Bn 12.70 Bn -
3 Merck 366.81 Bn 359.67 Bn 12.21 Bn -
4 Novartis Ag 266.82 Bn 259.13 Bn 11.24 Bn -
5 Pfizer 159.37 Bn 147.67 Bn 10.94 Bn -
6 Sanofi 52.46 Bn 45.08 Bn 10.79 Bn -
7 Revolution Medicines 44.12 Bn 44.12 Bn - -
8 Incyte 25.49 Bn 20.95 Bn 1.57 Bn -
9 United Therapeutics 21.55 Bn 18.89 Bn 683.80 Mn -
10 Regencell Bioscience Holdings 75.87 Mn 73.51 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2022 301,085.00